Search
Advertisement
PB Fintech share surge 7% as arm gets license upgrade from Irdai

PB Fintech share surge 7% as arm gets license upgrade from Irdai

PB Fintech's wholly-owned subsidiary, Policybazaar Insurance Brokers (Policybazaar), has received the nod from the Insurance Regulatory and Development Authority of India (Irdai) to upgrade its license from a direct insurance broker to a composite insurance broker.

Prashun Talukdar
Prashun Talukdar
  • Updated Feb 19, 2024 10:45 AM IST
PB Fintech share surge 7% as arm gets license upgrade from IrdaiPB Fintech share surge 7% as arm gets license upgrade from Irdai

Shares of PB Fintech Ltd jumped 6.92 per cent to hit a day high of Rs 996.35 in Monday's trade. At this price, the stock was trading 5.12 per cent from its one-year high value of Rs 1,050.10, a level seen earlier this month on February 1.

PB Fintech's wholly-owned subsidiary, Policybazaar Insurance Brokers (Policybazaar), has received the nod from the Insurance Regulatory and Development Authority of India (Irdai) to upgrade its license from a direct insurance broker to a composite insurance broker.

Advertisement

It largely translates that the company can now also sell reinsurance products besides general and life insurance products.

The company reported its first quarterly profit since listing, as growing demand for insurance boosted revenue. PB Fintech, which also operates online credit marketplace Paisabazaar, posted a consolidated net profit of Rs 38.05 crore for the quarter ended December 31 (Q3 FY24), against a loss of Rs 87.3 crore a year ago.

Revenue from operations rose nearly 43 per cent to Rs 871 crore as proceeds from its insurance broker services more-than-doubled.

Revenue from its core online business of Policybazaar and Paisabazaar rose 39 per cent to Rs 593 crore.

The company said new premium for health and term insurance business grew by 44 per cent. While total costs rose nearly 21 per cent. Advertising and promotion expenses dipped 28 per cent from the year-ago period.

Advertisement

Also read | Stock recommendations by analyst for February 19: Adani Ports, SBI Life and Tata Consumer

Also read | Zenith Drugs IPO opens today: Price band, issue size, listing date and more

Disclaimer: Business Today provides stock market news for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.

ABOUT THE AUTHOR

Prashun Talukdar
Prashun Talukdar

With a long experience in the digital space, Prashun has seen it all (mostly at least). From dot-com bubbles to crypto crazes. When it comes to covering the stock markets, he is constantly on the trail to look out for the next big trend. But don't let the seriousness of the stock market fool you. Outside of work, you can often find him strolling Insta, scrolling through memes or binge-watching cartoons.

And when Prashun is not glued to his phone, he's checking out the latest automobile launches – because let's face it, who doesn't love a good car or bike show? So, watch this space for reading regular updates and insights into the world of stock markets. Motto: Live and let live!

Published on: Feb 19, 2024 10:31 AM IST